[1]
MENEZES, A.D. and FRAIJI, N.A. 2020. Use of tyrosine kinase inhibitor by patients with chronic myeloid leukemia at a public hematology institution in the state of Amazonas, Brazil. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 11, 4 (Nov. 2020), 510. DOI:https://doi.org/10.30968/rbfhss.2020.114.0510.